ANA CZARINA BUTAC: Open Payments
NPI 1427528272 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 10 payments from 6 companies in 2025. Trend: 2023 $993 · 2024 $167 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $429 |
| Celltrion USA Inc. | 1 | $131 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $123 |
| Lilly USA, LLC | 2 | $97 |
| ABBVIE INC. | 1 | $49 |
Products named: TREMFYA, ZYMFENTRA, XIFAXAN, ZENPEP, OMVOH, SKYRIZI.
Industry payments across WA — which companies pay providers there.
